7-Bromo-5-chloro-1H-indole

Catalog No.: 
ACUXWI908
CAS No.: 
292636-08-9
Molecular Formula: 
C8H5BrClN
Molecular Weight: 
230.49
7-Bromo-5-chloro-1H-indole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$194.00In stockIn stock
10g95%$361.00In stockIn stock
25g95%$722.00In stockInquiry
100g95%$2308.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromo-5-chloro-1H-indole
IUPAC Name7-bromo-5-chloro-1H-indole
MDL No.MFCD09880061
Molecular FormulaC8H5BrClN
Molecular Weight230.49
SMILESClC1=CC2=C(NC=C2)C(Br)=C1
InChI KeyCBQDZTGRYHTJRO-UHFFFAOYSA-N
SynonymAS-33244 | CBQDZTGRYHTJRO-UHFFFAOYSA-N | CS-D0780 | SCHEMBL1397681 | MFCD09880061 | FT-0647049 | DTXSID00646826 | AKOS016002904 | AMY7453 | 7-Bromo-5-chloroindole | SY029986 | EN300-202955 | SB36415 | AC-25173
CAS No.292636-08-9
PubChem CID24729504

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUXWI908 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPFAS429 route compound structure diagram
    ACPFAS429875306-23-3In Stock
  2. Plus
  3. ACYGKA349 route compound structure diagram
    ACYGKA349873-38-1In Stock
  4. Then
  5. ACUXWI908 route product structure diagram
    ACUXWI908292636-08-9In Stock
Inquiry

2. ACUXWI908 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRCF053 route compound structure diagram
    ACBRCF05363860-31-1In Stock
  2. Then
  3. ACUXWI908 route product structure diagram
    ACUXWI908292636-08-9In Stock
Inquiry

3. ACUXWI908 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUXWI908 route product structure diagram
    ACUXWI908292636-08-9In Stock
Inquiry

Comments (0)